|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2878 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 14/435 | (2013.01) | ||
| C07K 14/47 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K 19/00 | (2006.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2318/20 | (2013.01) | ||
| C07K2319/00 | (2013.01) | ||
| C07K 16/32 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3292148 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16721154.9 |
| Date of filing the European patent application | 2016-05-04 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/060041 |
| Date | 2016-05-04 |
| (87) | Number | WO 2016/177802 |
| Date | 2016-11-10 |
| (30) | Number | Date | Country code |
| 15166179 | 2015-05-04 | EP | |
| 15167917 | 2015-05-18 | EP | |
| 15002702 | 2015-09-17 | EP | |
| 15192870 | 2015-11-04 | EP | |
| 16150705 | 2016-01-11 | EP | |
| 16000862 | 2016-04-15 | EP |
| (72) |
HINNER, Marlon , DE
ROTHE, Christine , DE
OLWILL, Shane , DE
BEL AIBA, Rachida, Siham , DE
MOEBIUS, Ulrich , DE
SCHLOSSER, Corinna , DE
JAQUIN, Thomas, Jean , DE
|
| (73) |
Pieris Pharmaceuticals GmbH ,
Zeppelinstrasse 3, 85399 Hallbergmoos,
DE
|
| (54) | ANTI-CANCER FUSION POLYPEPTIDE |
| ANTI-CANCER FUSION POLYPEPTIDE |